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Background: Prediction of mode of death, pump failure death (PFD) or sudden cardiac death (SCD), in patients with chronic heart failure (CHF) 
may facilitate decisions about specific medications or devices. It is of clinical significance to predict the mortality from simple and inexpensive tests, 
such as the 6-minute walk test (6MWT). However, there is little information on the long-term prognostic significance of 6MWT, relating to the mode 
of death, in patients with mild to moderate CHF, and it remains unclear whether serial studies of 6MWT would improve the prediction of the clinical 
outcome.
Methods and Results: We prospectively studied 145 CHF outpatients (NYHA class: 2.0±0.6) with left ventricular ejection fraction < 40%. At the 
entry, 6MWT was performed, and repeated every 1 to 2 months for the initial 3 years. During the follow-up period of >10 yrs, 15 patients had PFD 
and 26 patients had SCD. At multivariate Cox analysis, 6MWT distance at the entry was independently strongly (p=0.0008) associated with PFD, while 
6MWT distance at the entry has no significant association with SCD. Furthermore, the area under receiver operating curve, with 6MWT distance at 
the last evaluation, used to predict PFD was 0.763 (95% CI: 0.623 to 0.903, p=0.001), which was greater than that with 6MWT distance at the entry 
(0.644, 95% CI: 0.484 to 0.803, p=0.069).
Conclusion: In patients with mild to moderate CHF, 6MWT distance is a simple prognostic marker of PFD, not SCD, and serial studies of 6MWT 
could improve the prediction of PFD.
